Schrödinger Obtains $10,000,000 New Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f6eba5d7-853b-4c00-a17d-0d0ca3e199fd&Preview=1 -
Date
4/29/2010 -
Company Name
Schrödinger -
Mailing Address
120 West 45th Street 17th Floor, Tower 45 New York, NY 10036-4041 -
Company Description
Schrödinger makes significant investments in R&D, which has led to major advances in the field of computational chemistry. Working closely with its scientific advisory board – a distinguished group of leading academic and industrial scientists who collectively have over one thousand publications with over 50,000 citations – Schrödinger has achieved breakthroughs in quantum chemistry, molecular modeling, force fields, molecular dynamics, protein structure determination, and docking. Schrödinger’s methods development and applications papers have over one thousand citations and are often among the most-cited scientific publications. Schrödinger’s science is extensively validated by its growing legion of loyal users. -
Website
http://www.schrodinger.com -
Transaction Type
Venture Equity -
Transaction Amount
$10,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
The money will be used to support R&D projects to advance the state of the art in computer-aided drug design. -
M&A Terms
-
Venture Investor
Cascade Investment
